Vista BioMedical™, Inc. Introduces VPAATH©, an AI-Based Program that Identifies Individual High Risk, High Utilizing Patients Using Social Determinants of Health Factors View more
inFormed Consent Announces the Launch of Remote Procedural Consent and the inFormed Consent Platform into the Clinical Research Organization and Pharmaceutical Markets View more
MEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer Models View more
